1. Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy
    Swati Bhattacharyya et al, 2017, Immunology Letters CrossRef
  2. Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury
    Luciana Lassance et al, 2018, Experimental Eye Research CrossRef
  3. Epidermal HMGB1 Activates Dermal Fibroblasts and Causes Hypertrophic Scar Formation in Reduced Hydration
    Jingling Zhao et al, 2018, Journal of Investigative Dermatology CrossRef
  4. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts
    Qian Zhang et al, 2018, J Cell Biochem CrossRef
  5. Role of DAMPs in Tissue Regeneration and Repair
    Walter Gottlieb Land, 2018 CrossRef
  6. Molecular Mechanisms and Potential Therapeutic Targets in Incisional Hernia
    Finosh G. Thankam et al, 2019, Journal of Surgical Research CrossRef
  7. Protocol for the long-term culture of human primary keratinocytes from the normal colorectal mucosa
    Elena Torreggiani et al, 2019, J Cell Physiol CrossRef
  8. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF‐β1/Smad signaling pathway
    Yang Jiang et al, 2019, J. Pathol. CrossRef
  9. Nuclear Damage Associated Molecular Pattern (DAMP) Molecule HMGB1 in the Pathogenesis of Lung Diseases
    Mao Wang et al, 2019, Antioxidants & Redox Signaling CrossRef
  10. NLRP6 deficiency aggravates liver injury after allogeneic hematopoietic stem cell transplantation
    Mingfeng Li et al, 2019, International Immunopharmacology CrossRef
  11. Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule
    Preethi Vijayaraj et al, 2019, Cell Reports CrossRef
  12. GSPE alleviates renal fibrosis by inhibiting the activation of C3/ HMGB1/ TGF-β1 pathway
    Kun Wang et al, 2019, Chemico-Biological Interactions CrossRef
  13. Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation
    Meirong Huo et al, 2020, Journal of Controlled Release CrossRef
  14. Alternatively activated macrophages are associated with the α2AP production that occurs with the development of dermal fibrosis
    Yosuke Kanno et al, 2020, Arthritis Res Ther CrossRef
  15. HIP/PAP protects against bleomycin‐induced lung injury and inflammation and subsequent fibrosis in mice
    Xiaoyan Zheng et al, 2020, J Cell Mol Med CrossRef
  16. Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast–to-myofibroblast transition
    Haobo Lin et al, 2020, Advances in Medical Sciences CrossRef
  17. The Growing World of DAMPs
    Walter Gottlieb Land, 2020 CrossRef
  18. DAMP-Promoted Efferent Innate Immune Responses in Human Diseases: Fibrosis
    Walter Gottlieb Land, 2020 CrossRef
  19. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
    Kota Araki et al, 2020, J Mol Med CrossRef
  20. The puzzling pathophysiology of frozen shoulders – a scoping review
    T. Kraal et al, 2020, J EXP ORTOP CrossRef
  21. Dysregulation of Transcription Factor Activity During Formation of Cancer-Associated Fibroblasts
    Przemysław Kapusta et al, 2020, IJMS CrossRef
  22. Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling
    Huijuan Zou et al, 2021, Front. Immunol. CrossRef
  23. Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis
    Jade Jaffar et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  24. TLR-4 Signaling in Pericytes
    Alessandra Stasi et al, 2021 CrossRef
  25. The potential role of the adipokine HMGB1 in obesity and insulin resistance. Novel effects on adipose tissue biology
    R. Guzmán-Ruiz et al, 2021, Molecular and Cellular Endocrinology CrossRef
  26. miR‐627/HMGB1/NF‐κB regulatory loop modulates TGF‐β1‐induced pulmonary fibrosis
    Jie Li et al, 2019, J Cell Biochem CrossRef
  27. Research Progress of High-Mobility Group Box Protein B1 in Respiratory Diseases
    润玉 邵, 2021, ACM CrossRef
  28. Expression and possible role of Smad3 in postnecrotizing enterocolitis stricture
    Rui Chen et al, 2022, World Jnl Ped Surgery CrossRef
  29. Targeting Danger Signals to Rescue Fibrosis
    Konstantin Tsoyi et al, 2022, Am J Respir Cell Mol Biol CrossRef
  30. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation
    Kakuhiro Yamaguchi et al, 2022, Respiratory Investigation CrossRef
  31. Hylocereus undatus flower extract suppresses OVA-induced allergic asthma in BALb/c mice by reducing airway inflammation and modulating gut microbiota
    Wanzhong Liao et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  32. Inhibiting S100A8/A9 attenuates airway obstruction in a mouse model of heterotopic tracheal transplantation
    Dai Shimizu et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  33. The combination of exercise and metformin inhibits TGF-β1/Smad pathway to attenuate myocardial fibrosis in db/db mice by reducing NF-κB–mediated inflammatory response
    Jingjing Liu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  34. Predictive investigation of idiopathic pulmonary fibrosis subtypes based on cellular senescence-related genes for disease treatment and management
    Changqing Yang et al, 2023, Front. Genet. CrossRef
  35. Anti‐fibrotic effect of ciglitazone in HRV‐induced airway remodelling cell model
    Joanna Wieczfinska et al, 2023, J Cellular Molecular Medi CrossRef
  36. Incidence, risk factors, and predictive modeling of stoma site incisional hernia after enterostomy closure: a multicenter retrospective cohort study
    Yonghuan Mao et al, 2023, BMC Gastroenterol CrossRef
  37. Advances in the roles of glycyrrhizic acid in cancer therapy
    Yuqian Zhang et al, 2023, Front. Pharmacol. CrossRef
  38. Epithelial alarmins: a new target to treat chronic respiratory diseases
    Denislava Nedeva et al, 2023, Expert Review of Respiratory Medicine CrossRef
  39. Oleate alters the immune response in non-small cell lung adenocarcinoma through regulation of HMGB1 release
    Breanna Cole-Skinner et al, 2024, Front. Cell Dev. Biol. CrossRef
  40. Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection
    Yoji Komiya et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  41. Pharmacological targets and validation of remdesivir for the treatment of COVID-19-associated pulmonary fibrosis: A network-based pharmacology and bioinformatics study
    Xueping Zhao et al, 2024 CrossRef
  42. Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study
    Jovana Kuveljic et al, 2024, Genes CrossRef
  43. An anti-RAGE chimeric antibody alleviates CCl4-induced liver fibrosis via RAGE/NF-kB pathway in mice
    Jing Liu et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  44. The Effect of Metformin on Radiation-Induced Lung Fibrosis in Mice
    Yu-Zhong Chen et al, 2024, Dose-Response CrossRef
  45. Terminology, Pathophysiology, and Natural History of Frozen Shoulder
    Myung Woo Park, 2024, Clinical Pain CrossRef